Apraclonidine Hydrochloride and Didanosine Delayed-Release Enteric-Coated Capsules
Determining the interaction of Apraclonidine Hydrochloride and Didanosine Delayed-Release Enteric-Coated Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine ophthalmic, Apraclonidine
Generic Name: didanosine
Brand name: Videx, Videx EC
Synonyms: Didanosine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine Hydrochloride-Didanosine Oral Solution
- Apraclonidine Hydrochloride-Didanosine Tablet, for suspension
- Apraclonidine Hydrochloride-Didrex
- Apraclonidine Hydrochloride-Didronel
- Apraclonidine Hydrochloride-Dienogest and estradiol
- Apraclonidine Hydrochloride-Diethylene Triamine Penta-Acetic Acid
- Didanosine Delayed-Release Enteric-Coated Capsules-Apraclonidine ophthalmic
- Didanosine Delayed-Release Enteric-Coated Capsules-Apremilast
- Didanosine Delayed-Release Enteric-Coated Capsules-Aprepitant
- Didanosine Delayed-Release Enteric-Coated Capsules-Aprepitant Capsules
- Didanosine Delayed-Release Enteric-Coated Capsules-Aprepitant Injection
- Didanosine Delayed-Release Enteric-Coated Capsules-Aprepitant Intravenous